Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

203 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Survival Outcomes of Patients with Primary Plasma Cell Leukemia in the Era of Proteasome Inhibitors and Immunomodulatory Agents: A Real-Life Multicenter Analysis.
Ataş Ü, Salim O, Iltar U, Yücel OK, Küçükdiler Eroğlu AH, Aslan V, Yıldırım M, Dedeoğlu Ö, Seçilmiş S, Ulaş T, Deveci B, Karaman Gulsaran S, Gedük A, Yaman F, Pınar İE, Maral S, Sarıcı A, Çelik S, Oğul H, Gülkan Özkan S, Gemici A, Güneş AK, Tombak A, Yavaşoğlu İ, Karakuş V, Cömert M, Toptaş T, Dal MS, Saba R, Kırkızlar HO, Mehtap Ö, Gündüz E, Özkalemkaş F, Albayrak M, Berber İ, Keklik M, Güler N, Özkan HA, Sevindik ÖG, Bolaman Z, Kurtoğlu E, Aylı M, Fıratlı Tuğlular T, Altuntaş F, Ündar L. Ataş Ü, et al. Among authors: ulas t. Turk J Haematol. 2024 Dec 2;41(4):225-235. doi: 10.4274/tjh.galenos.2024.2023.0450. Epub 2024 Nov 6. Turk J Haematol. 2024. PMID: 39501735 Free PMC article.
What should be the optimal dose of post-transplantation cyclophosphamide for GVHD prophylaxis in allogeneic stem cell transplantation?
Ulas T, Namdaroglu S, Hindilerden IY, Erkurt MA, Erer K, Yigenoglu TN, Tiryaki TO, Hidayet E, Korkmaz S, Ulu BU, Yilmaz S, Kaya E, Pepeler MS, Basturk A, Dal MS, Altuntas F. Ulas T, et al. Transfus Apher Sci. 2024 Dec 17;64(1):104058. doi: 10.1016/j.transci.2024.104058. Online ahead of print. Transfus Apher Sci. 2024. PMID: 39700842 Review.
Effectiveness of ibrutinib in the management of chronic GVHD.
Erkurt MA, Sarici A, Sahin A, Berber I, Korkmaz G, Kuku I, Dal MS, Korkmaz S, Ulas T, Altuntas F. Erkurt MA, et al. Among authors: ulas t. Transfus Apher Sci. 2024 Dec 16;64(1):104052. doi: 10.1016/j.transci.2024.104052. Online ahead of print. Transfus Apher Sci. 2024. PMID: 39706127 Review.
Efficacy of Ruxolitinib in the management of chronic GVHD.
Giden AO, Erkurt MA, Hindilerden IY, Hidayet E, Berber I, Tiryaki TO, Zorlu T, Namdaroglu S, Sarici A, Aksoy E, Yildizhan E, Aydin MS, Korkmaz S, Dal MS, Ulas T, Altuntas F. Giden AO, et al. Among authors: ulas t. Transfus Apher Sci. 2024 Dec 17;64(1):104053. doi: 10.1016/j.transci.2024.104053. Online ahead of print. Transfus Apher Sci. 2024. PMID: 39708419
Is there a relationship between vitamin D levels and graft versus host disease?
Yigenoglu TN, Ulu BU, Namdaroglu S, Erkurt MA, Sahin R, Okumus N, Yilmaz S, Ceran F, Koca M, Hatipoglu U, Dal MS, Korkmaz S, Ulas T, Altuntas F. Yigenoglu TN, et al. Among authors: ulas t. Transfus Apher Sci. 2024 Dec 16;64(1):104054. doi: 10.1016/j.transci.2024.104054. Online ahead of print. Transfus Apher Sci. 2024. PMID: 39709787
The role of ruxolitinib in the management of acute GVHD.
Namdaroglu S, Hidayet E, Aydin MS, Erkurt MA, Berber I, Cinar OE, Ozet G, Yilmaz S, Apaydin M, Dal MS, Korkmaz S, Basturk A, Ulaş T, Altuntas F. Namdaroglu S, et al. Among authors: ulas t. Transfus Apher Sci. 2024 Dec 16;64(1):104055. doi: 10.1016/j.transci.2024.104055. Online ahead of print. Transfus Apher Sci. 2024. PMID: 39719750
Are mesenchymal stem cells still effective in acute GvHD management?
Ulu BU, Hindilerden IY, Yigenoglu TN, Tiryaki TO, Erkurt MA, Korkmaz G, Namdaroglu S, Aksoy E, Korkmaz S, Seyhan M, Yilmaz S, Besisik SK, Dal MS, Ulas T, Altuntas F. Ulu BU, et al. Among authors: ulas t. Transfus Apher Sci. 2024 Dec 16;64(1):104051. doi: 10.1016/j.transci.2024.104051. Online ahead of print. Transfus Apher Sci. 2024. PMID: 39721135
A clinical protocol for a German birth cohort study of the Maturation of Immunity Against respiratory viral Infections (MIAI).
Hartmann CR, Khan R, Schöning J, Richter M, Willers M, Pirr S, Heckmann J, Dirks J, Morbach H, Konrad M, Fries E, Winkler M, Büchel J, Seidenspinner S, Fischer J, Vollmuth C, Meinhardt M, Marissen J, Schmolke M, Haid S, Pietschmann T, Backes S, Dölken L, Löber U, Keil T, Heuschmann PU, Wöckel A, Sagar, Ulas T, Forslund-Startceva SK, Härtel C, Viemann D. Hartmann CR, et al. Among authors: ulas t. Front Immunol. 2024 Sep 17;15:1443665. doi: 10.3389/fimmu.2024.1443665. eCollection 2024. Front Immunol. 2024. PMID: 39355253 Free PMC article.
203 results